Global Pharmatech Inc
OTC:GBLP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Global Pharmatech Inc
Pre-Tax Income
Global Pharmatech Inc
Pre-Tax Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Pre-Tax Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Global Pharmatech Inc
OTC:GBLP
|
Pre-Tax Income
-$2.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Hengan International Group Company Ltd
HKEX:1044
|
Pre-Tax Income
¥3.2B
|
CAGR 3-Years
4%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-3%
|
|
|
Proya Cosmetics Co Ltd
SSE:603605
|
Pre-Tax Income
¥1.8B
|
CAGR 3-Years
17%
|
CAGR 5-Years
26%
|
CAGR 10-Years
N/A
|
|
|
Yunnan Botanee Bio-Technology Group Co Ltd
SZSE:300957
|
Pre-Tax Income
¥608.4m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
|
|
By-health Co Ltd
SZSE:300146
|
Pre-Tax Income
¥1B
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
3%
|
|
|
G
|
Giant Biogene Holding Co Ltd
HKEX:2367
|
Pre-Tax Income
¥2.4B
|
CAGR 3-Years
26%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
|
Global Pharmatech Inc
Glance View
Global Pharmatech, Inc. engages in the discovery, development, manufacture, and marketing of proprietary drugs developed based on traditional Chinese medicine. The company is headquartered in Changchun, Jilin and currently employs 217 full-time employees. The company went IPO on 2006-05-12. Ltd., is a contract manufacturer of liquid sterile formulations in small volume glass vials and ampoules, and large volume glass bottles The Company has manufactured products in various therapeutic segments such as Vitamin Supplements, Anaesthetics, Corticosteroids, Anti-emetics, Steroids with antibiotics, Anemia, Analgesics, Antihistamines, Anti Filarial. Its first product, Iron Sucrose, is being marketed in India. The company offers the products for domestic as well as international market. Its products include Iron Sucrose Injection USP, Ondansetron Injection USP, Promethazine Injection BP, Tramadol HCI Injection, Metoclopramide Injection BP, Levetiracetam Injection and Amikacin Injection. The firm registers products in various markets around the world.
See Also
What is Global Pharmatech Inc's Pre-Tax Income?
Pre-Tax Income
-2.5m
USD
Based on the financial report for Dec 31, 2007, Global Pharmatech Inc's Pre-Tax Income amounts to -2.5m USD.
What is Global Pharmatech Inc's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 1Y
-177%
Over the last year, the Pre-Tax Income growth was -177%.
